Xeris Biopharma Holdings, Inc. (XERS) short interest & options flow
NASDAQXERS heads into its November 5 earnings report with a sharp single-day sell-off, elevated retail attention, and an analyst community that has been steadily raising its view on the stock. The most striking data point this week is not in the borrow market. It is in retail interest. Wikipedia views and ORTEX page traffic for Xeris Biopharma have produced a z-score of 5.74 against the…
XERS cost to borrow surges 601% over one week to 0.52%, though remains at historically low levels overall.
- Market cap
- $2.78B
- Next earnings
- 5 Mar 2027
Key data as of 8 Nov 2026
Latest signals on XERS
- Cost to Borrow
XERS cost to borrow surges 601% over one week to 0.52%, though remains at historically low levels overall.
2 Cost to Borrow updates in 30 days
XERS news and analysis
RSSNo long-form analysis yet for XERS. Pulse alerts and the live data picture are available on ORTEX.
Open XERS on ORTEX →Want the live picture for XERS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for XERS — free to start on ORTEX.
Sign up for free →Open XERS on ORTEX